Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference

Rhea-AI Summary

Organon (NYSE: OGN) announced that CEO Kevin Ali and CFO Matthew Walsh will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on December 1, 2021, at 1:50 p.m. ET. Investors, analysts, and the public can access a live video webcast at this link. Organon focuses on women's health and has over 60 products across various therapeutic areas, serving over 140 markets globally and employing approximately 9,000 people.

JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1, 2021 at 1:50 p.m. ET.

Investors, analysts, members of the media and the general public are invited to watch a live video webcast of the presentation at https://www.organon.com/investor-relations/events-and-presentations/.

About Organon

Organon is a global healthcare company formed through a spin-off from Merck, (NYSE: MRK) known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint that serves people in over 140 markets, world-class commercial capabilities and approximately 9,000 employees with headquarters located in Jersey City, New Jersey.

For more information, visit http://www.organon.com and connect with us on LinkedIn and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211122005098/en/

Media Contacts:

Karissa Peer

(614) 314-8094

Kate Vossen

(732) 675-8448

Investor Contacts:

Jennifer Halchak

(201) 275-2711

Edward Barger

(267) 614-4669

Source: Organon & Co.

FAQ

When is the Organon fireside chat scheduled at the Evercore ISI HealthCONx Conference?

The Organon fireside chat is scheduled for December 1, 2021, at 1:50 p.m. ET.

Who will represent Organon in the fireside chat at the HealthCONx Conference?

CEO Kevin Ali and CFO Matthew Walsh will represent Organon in the fireside chat.

How can I watch the Organon presentation at the HealthCONx Conference?

You can watch the Organon presentation live via webcast at this link.

What does Organon focus on regarding its product offerings?

Organon focuses on women's health, with a portfolio of over 60 medicines and products across various therapeutic areas.

What is the stock symbol for Organon and Merck?

The stock symbol for Organon is OGN, and for Merck, it is MRK.